Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/26/1994 | CA2149641A1 Methods for converting a, ab and b blood types to o blood type |
05/26/1994 | CA2149626A1 Formation of triple helix complexes of single stranded nucleic acids using nucleoside oligomers which comprise pyrimidine analogs |
05/26/1994 | CA2149318A1 Identification of neoplasms by detection of genetic insertions and deletions |
05/26/1994 | CA2149309A1 Heat shock proteins and the treatment of tumours |
05/26/1994 | CA2149249A1 A representational approach to dna analysis |
05/26/1994 | CA2149212A1 Improved recombinant production of proteins having factor viii:c activity |
05/26/1994 | CA2149056A1 Novel polypeptides with opioid receptor activity, nucleic acids encoding these substances and uses thereof |
05/26/1994 | CA2148838A1 Soluble peptides having constrained, secondary conformation in solution and method of making same |
05/26/1994 | CA2148835A1 Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs |
05/26/1994 | CA2148829A1 Avirulent live vaccine and method for immunizing animals against p. multocida pasteurellosis |
05/26/1994 | CA2148713A1 Allergenic proteins and peptides from japanese cedar pollen |
05/26/1994 | CA2148687A1 Antisense oligonucleotides to inhibit expression of mutated and wild type genes for collagen |
05/26/1994 | CA2148484A1 Novel cytokine designated elk ligand |
05/26/1994 | CA2147122A1 Biocidal chitin binding proteins |
05/26/1994 | CA2146160A1 Oligoprobe designstations: a computerized method for designing optimal oligonucleotide probes and primers |
05/26/1994 | CA2138009A1 Production of monoclonal recombinant antibodies without the use of hybridomas by iin vitro spleen fragment culture combined with isothermal self-sustained sequence replication of rna |
05/26/1994 | CA2127531A1 Materials and methods for immunocontraception |
05/26/1994 | CA2108834A1 Isolated silver fox growth hormone gene, and a recombinant dna thereof |
05/26/1994 | CA2083812A1 Expression vectors and their use in the preparation of hiv-resistant human cells for therapeutic applications |
05/25/1994 | EP0598589A2 Method for the production of proteins in plant fluids |
05/25/1994 | EP0598493A1 Recombinant vector, method for giving immunity against PVY-T to potato plant, and potato plant having immunity against PVY-T |
05/25/1994 | EP0598332A2 Method for nucleic acid amplification |
05/25/1994 | EP0598329A2 Simultaneous determination of HbA1c and haemoglobin variants with a HbA1c analog glycation |
05/25/1994 | EP0598108A1 Rabbit single domain antibody and use thereof |
05/25/1994 | EP0598029A1 Retroviral vectors containing internal ribosome entry sites |
05/25/1994 | EP0598011A1 Ecdysteroid dependent regulation of genes in mammalian cells |
05/25/1994 | EP0598002A1 Viral vector-based insecticides and expression systems |
05/25/1994 | EP0598000A1 Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies oxa and oxb |
05/25/1994 | EP0597984A1 Device for detecting aqueous contaminants |
05/25/1994 | EP0597964A1 Proliferation of hepatocyte precursors |
05/25/1994 | EP0597960A1 Treatment of cell populations |
05/25/1994 | EP0597845A1 GROWTH FACTOR WHICH INHIBITS THE GROWTH OF CELLS OVEREXPRESSING THE HUMAN ONCOGENE erbB-2 |
05/25/1994 | EP0597844A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
05/25/1994 | EP0597843A1 16 kDa SURFACE PROTEIN OF $i(P. FALCIPARUM) |
05/25/1994 | EP0597842A1 Metal binding proteins |
05/25/1994 | EP0597829A1 Novel monoclonal antibody to novel antigen associated with human tumors |
05/25/1994 | EP0252146B1 Nuclear factors associated with transcriptional regulation |
05/25/1994 | CN1087118A A transformant capable of producing d-amino acid oxidase |
05/25/1994 | CA2103323A1 Her4 human receptor tyrosine kinase |
05/24/1994 | US5315001 Acyl carrier protein - DNA sequence and synthesis |
05/24/1994 | US5314995 Antitumor |
05/24/1994 | US5314994 Inhibitor of tissue-type and urokinase-type plasminogen activators |
05/24/1994 | US5314991 Recombinant 40 KDa Dermatophagoides farinae allergen |
05/24/1994 | US5314872 Glucan sulfate, stabilized fibroblast growth factor composition |
05/24/1994 | US5314819 Protein having nitrile hydratase activity obtained from rhizobium, gene encoding the same, and a method for producing amides from nitriles via a transformant containing the gene |
05/24/1994 | US5314818 Human tissue plasminogen activator variants |
05/24/1994 | US5314817 Catalytic and reactive polypeptides and methods for their preparation and use |
05/24/1994 | US5314813 Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines |
05/24/1994 | US5314809 Methods for nucleic acid amplification |
05/24/1994 | US5314808 Method for the transformation of cells, particularly eukaryotes by a DNA originating from viruses of hepatitis, more particularly from virus of a B viral hepatitis, and preparations containing the expression products of said DNAs |
05/24/1994 | US5314637 Detergent comprising isolated cellulase from bacillus ferm bp-3431 or a mutant strain thereof, surfactant and builder |
05/24/1994 | US5314595 Electrophoresis of nucleic acid fragments |
05/24/1994 | CA1329763C Stabilized fgf composition and production thereof |
05/19/1994 | DE4306627C1 Method for increasing the sugar and starch content in plants - by a vector including transcription regulatory sequences and a cDNA fragment from Poty virus for inclusion proteins |
05/19/1994 | DE4241659C1 New thrombin-inhibiting protein - used in treatment of thrombosis, angina and arteriosclerosis |
05/19/1994 | DE4238778A1 Vektor zur Expression von therapeutisch relevanten Genen Vector for Expression of therapeutically relevant genes |
05/19/1994 | DE4238416A1 Bestimmung von Peptidmotiven auf MHC-Molekülen Determination of peptide motifs on MHC molecules |
05/18/1994 | EP0597827A1 Fibroblast growth factor |
05/18/1994 | EP0597681A1 Expression vectors for the bovine trypsin and trypsinogen and host cells transformed therewith |
05/18/1994 | EP0597503A2 ECK receptor ligands |
05/18/1994 | EP0597185A1 Bacillus subtilis siderophore genes |
05/18/1994 | EP0597146A1 Modifying cell metabolism via extra-cellular nucleases |
05/18/1994 | EP0597035A1 Highly stable recombinant yeasts for the production of recombinant proteins |
05/18/1994 | EP0597016A1 Infectious bursal disease virus recombinant poxvirus vaccine |
05/18/1994 | EP0597010A1 Transgenic protein production |
05/18/1994 | EP0597008A1 Improved expression of influenza a m2 protein in baculovirus and uses of m2 protein |
05/18/1994 | EP0597006A1 New process for sequencing nucleic acids |
05/18/1994 | EP0596979A1 Recombinant plant viral nucleic acids |
05/18/1994 | EP0596969A1 Igf-ii analogues |
05/18/1994 | EP0596918A1 Amplification of target nucleic acids using gap filling ligase chain reaction |
05/18/1994 | EP0596901A1 CHIMERIC tRNA?LYS -RIBOZYME MOLECULES |
05/18/1994 | EP0596887A1 Genetically engineered mice containing alterations in the mhc class ii genes |
05/18/1994 | EP0596881A1 Expression in non-tumoral human lymphoblastoid lines with an integrative vector. |
05/18/1994 | EP0577598A4 Biologically safe plant transformation system |
05/18/1994 | EP0543889A4 Incorporation of selectably clevable and/or abasic sites into oligonucleotide chains and reagents therefor |
05/18/1994 | EP0502872B1 Methods and materials for expression of human plasminogen variant |
05/18/1994 | EP0463043B1 Method for stabilizing the hybridization of complementary polynucleotide sequences |
05/18/1994 | EP0380495B1 Serum free media for the growth of insect cells and expression of products thereby |
05/18/1994 | EP0335899B1 Immunoaffinity purification system |
05/18/1994 | EP0316429B1 Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation |
05/18/1994 | EP0283475B1 Enhanced secretion of heterologous proteins by hosts using substituted promoters |
05/18/1994 | EP0266399B1 Replicative rna reporter systems |
05/18/1994 | EP0248819B1 Recombinant fibroblast growth factors |
05/18/1994 | CA2103318A1 Simultaneous determination of hba1 and haemoglobin variants with a glycation analogous to hba1 |
05/18/1994 | CA2102963A1 Simple nucleic acid amplification |
05/17/1994 | US5312921 Dyes designed for high sensitivity detection of double-stranded DNA |
05/17/1994 | US5312912 Procedures and regulatory DNA sequences for genetically engineering disease resistance and other inducible traits in plants |
05/17/1994 | US5312911 Improved biological activity in the absence of heparin |
05/17/1994 | US5312910 Plant gene and DNA molecule encoding the synthase; using planted crop seed or plant which is glyphosate tolerant as a result of chimeric gene insertion to selectively control weeds in field containing seed or plant; N-phosphonomethylglycine |
05/17/1994 | US5312909 Recombinant DNA encoding neutral trehalase |
05/17/1994 | US5312901 Cloned streptococcal genes encoding protein G and their use to construct recombinant microorganisms to produce protein G |
05/17/1994 | US5312750 Genetic engineering for glucose detection |
05/17/1994 | US5312748 Protease |
05/17/1994 | US5312746 Cloning and expressing restriction endonucleases and modification methylases from caryophanon |
05/17/1994 | US5312743 Cholesterol esterases with variable substrate specificity |
05/17/1994 | US5312737 CKS method of HCV protein synthesis |
05/17/1994 | US5312736 DNA-sequence encoding the analog; expression vector containing the sequence; transformed or transfected microorganism or cell line comprising the vector; culture preparation of analog; drug including analog |
05/17/1994 | US5312735 Supersecreting mutants of saccharomyces cerevisiae |
05/17/1994 | US5312733 Developmental marker gene of CD4-CD8 thymocytes |
05/17/1994 | US5312732 Hormone receptor compositions and methods |